These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 21547477)
1. Clinical value of FDG-PET for preoperative evaluation of endometrial cancer. Suga T; Nakamoto Y; Saga T; Higashi T; Hamanaka Y; Tatsumi M; Hayashida K; Hara T; Konishi I; Fujii S; Togashi K Ann Nucl Med; 2011 May; 25(4):269-75. PubMed ID: 21547477 [TBL] [Abstract][Full Text] [Related]
2. High-grade endometrial cancer: value of [(18)F]FDG PET/CT in preoperative staging. Picchio M; Mangili G; Samanes Gajate AM; De Marzi P; Spinapolice EG; Mapelli P; Giovacchini G; Sigismondi C; Viganò R; Sironi S; Messa C Nucl Med Commun; 2010 Jun; 31(6):506-12. PubMed ID: 20168262 [TBL] [Abstract][Full Text] [Related]
3. Role of the integrated FDG PET/CT in the surgical management of patients with high risk clinical early stage endometrial cancer: detection of pelvic nodal metastases. Signorelli M; Guerra L; Buda A; Picchio M; Mangili G; Dell'Anna T; Sironi S; Messa C Gynecol Oncol; 2009 Nov; 115(2):231-5. PubMed ID: 19695685 [TBL] [Abstract][Full Text] [Related]
4. Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT. Crivellaro C; Signorelli M; Guerra L; De Ponti E; Pirovano C; Fruscio R; Elisei F; Montanelli L; Buda A; Messa C Gynecol Oncol; 2013 Aug; 130(2):306-11. PubMed ID: 23707673 [TBL] [Abstract][Full Text] [Related]
5. 18F-FDG PET in the management of endometrial cancer. Chao A; Chang TC; Ng KK; Hsueh S; Huang HJ; Chou HH; Tsai CS; Yen TC; Wu TI; Lai CH Eur J Nucl Med Mol Imaging; 2006 Jan; 33(1):36-44. PubMed ID: 16167154 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of Tsuyoshi H; Tsujikawa T; Yamada S; Okazawa H; Yoshida Y Cancer Imaging; 2020 Oct; 20(1):75. PubMed ID: 33092631 [TBL] [Abstract][Full Text] [Related]
7. Usefulness of (18)F-FDG PET in the post-therapy surveillance of endometrial carcinoma. Belhocine T; De Barsy C; Hustinx R; Willems-Foidart J Eur J Nucl Med Mol Imaging; 2002 Sep; 29(9):1132-9. PubMed ID: 12192557 [TBL] [Abstract][Full Text] [Related]
8. Value of fusion of PET and MRI for staging of endometrial cancer: comparison with ¹⁸F-FDG contrast-enhanced PET/CT and dynamic contrast-enhanced pelvic MRI. Kitajima K; Suenaga Y; Ueno Y; Kanda T; Maeda T; Takahashi S; Ebina Y; Miyahara Y; Yamada H; Sugimura K Eur J Radiol; 2013 Oct; 82(10):1672-6. PubMed ID: 23727380 [TBL] [Abstract][Full Text] [Related]
9. Performance of FDG-PET/CT in the diagnosis of recurrent endometrial cancer. Kitajima K; Murakami K; Yamasaki E; Hagiwara S; Fukasawa I; Inaba N; Kaji Y; Sugimura K Ann Nucl Med; 2008 Feb; 22(2):103-9. PubMed ID: 18311534 [TBL] [Abstract][Full Text] [Related]
10. FDG PET/CT diagnostic criteria may need adjustment based on MRI to estimate the presurgical risk of extrapelvic infiltration in patients with uterine endometrial cancer. Sudo S; Hattori N; Manabe O; Kato F; Mimura R; Magota K; Sugimori H; Hirata K; Sakuragi N; Tamaki N Eur J Nucl Med Mol Imaging; 2015 Apr; 42(5):676-84. PubMed ID: 25504022 [TBL] [Abstract][Full Text] [Related]
11. [Value of (18)F-FDG PET-CT in the preoperative N staging of non-small cell lung cancer]. Li M; Wu N; Liang Y; Zheng R; Liu Y; Zhang WJ; Zhao P Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):288-92. PubMed ID: 19615286 [TBL] [Abstract][Full Text] [Related]
12. Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma. Manohar K; Mittal BR; Senthil R; Kashyap R; Bhattacharya A; Singh G Nucl Med Commun; 2012 Jun; 33(6):591-6. PubMed ID: 22334135 [TBL] [Abstract][Full Text] [Related]
13. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients. Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of preoperative metabolic tumor volume measured by ¹⁸F-FDG PET/CT and MRI in patients with endometrial cancer. Chung HH; Lee I; Kim HS; Kim JW; Park NH; Song YS; Cheon GJ Gynecol Oncol; 2013 Sep; 130(3):446-51. PubMed ID: 23791826 [TBL] [Abstract][Full Text] [Related]
15. Improved detection of second primary cancer using integrated [18F] fluorodeoxyglucose positron emission tomography and computed tomography for initial tumor staging. Choi JY; Lee KS; Kwon OJ; Shim YM; Baek CH; Park K; Lee KH; Kim BT J Clin Oncol; 2005 Oct; 23(30):7654-9. PubMed ID: 16234527 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic performance of fluorine 18 fluorodeoxyglucose positron emission tomography imaging for detection of primary lesion and staging of endometrial cancer patients: systematic review and meta-analysis of the literature. Kakhki VR; Shahriari S; Treglia G; Hasanzadeh M; Zakavi SR; Yousefi Z; Kadkhodayan S; Sadeghi R Int J Gynecol Cancer; 2013 Nov; 23(9):1536-43. PubMed ID: 24172090 [TBL] [Abstract][Full Text] [Related]
17. 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) imaging in the staging and prognosis of inflammatory breast cancer. Alberini JL; Lerebours F; Wartski M; Fourme E; Le Stanc E; Gontier E; Madar O; Cherel P; Pecking AP Cancer; 2009 Nov; 115(21):5038-47. PubMed ID: 19645022 [TBL] [Abstract][Full Text] [Related]
18. Functional images reflect aggressiveness of endometrial carcinoma: estrogen receptor expression combined with 18F-FDG PET. Tsujikawa T; Yoshida Y; Kudo T; Kiyono Y; Kurokawa T; Kobayashi M; Tsuchida T; Fujibayashi Y; Kotsuji F; Okazawa H J Nucl Med; 2009 Oct; 50(10):1598-604. PubMed ID: 19759112 [TBL] [Abstract][Full Text] [Related]
19. Clinical value of FDG-PET in the follow up of post-operative patients with endometrial cancer. Saga T; Higashi T; Ishimori T; Mamede M; Nakamoto Y; Mukai T; Fujita T; Togashi K; Yura S; Higuchi T; Kita M; Fujii S; Konishi J Ann Nucl Med; 2003 May; 17(3):197-203. PubMed ID: 12846541 [TBL] [Abstract][Full Text] [Related]
20. Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors. Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY Oral Oncol; 2009 Mar; 45(3):218-24. PubMed ID: 18804404 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]